Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Role of oxidative stress in Parkinson's disease.

Hwang O.

Exp Neurobiol. 2013 Mar;22(1):11-7. doi: 10.5607/en.2013.22.1.11. Epub 2013 Mar 31.

PMID:
23585717
[PubMed]
Free PMC Article
2.

Oxidative stress indices in Parkinson's disease : biochemical determination.

Youdim MB, Drigues N, Mandel S.

Methods Mol Med. 2001;62:137-53. doi: 10.1385/1-59259-142-6:137.

PMID:
21318773
[PubMed]
3.

Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.

Lim JH, Kim KM, Kim SW, Hwang O, Choi HJ.

Pharmacol Res. 2008 May;57(5):325-31. doi: 10.1016/j.phrs.2008.03.004. Epub 2008 Mar 22.

PMID:
18455424
[PubMed - indexed for MEDLINE]
4.

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL.

Brain. 2005 Nov;128(Pt 11):2654-64. Epub 2005 Jul 6.

PMID:
16000336
[PubMed - indexed for MEDLINE]
Free Article
5.

Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease.

Farooqui T, Farooqui AA.

Parkinsons Dis. 2011 Feb 15;2011:247467. doi: 10.4061/2011/247467.

PMID:
21403820
[PubMed]
Free PMC Article
6.

Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

Tansey MG, Goldberg MS.

Neurobiol Dis. 2010 Mar;37(3):510-8. doi: 10.1016/j.nbd.2009.11.004. Epub 2009 Nov 10. Review.

PMID:
19913097
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.

Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J.

FASEB J. 2005 Apr;19(6):533-42.

PMID:
15791003
[PubMed - indexed for MEDLINE]
Free Article
8.

Metals, oxidative stress and neurodegenerative disorders.

Jomova K, Vondrakova D, Lawson M, Valko M.

Mol Cell Biochem. 2010 Dec;345(1-2):91-104. doi: 10.1007/s11010-010-0563-x. Epub 2010 Aug 22. Review.

PMID:
20730621
[PubMed - indexed for MEDLINE]
9.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
[PubMed - indexed for MEDLINE]
10.

Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.

Büeler H.

Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Review.

PMID:
19303005
[PubMed - indexed for MEDLINE]
11.

[Mechanism of specific dopaminergic neuronal death in Parkinson's disease].

Ogawa N, Asanuma M, Miyoshi K.

Nihon Rinsho. 2004 Sep;62(9):1629-34. Review. Japanese.

PMID:
15462376
[PubMed - indexed for MEDLINE]
12.

GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.

Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, Björklund A.

Brain. 2011 Aug;134(Pt 8):2302-11. doi: 10.1093/brain/awr149. Epub 2011 Jun 28.

PMID:
21712347
[PubMed - indexed for MEDLINE]
Free Article
13.

Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines.

Nagatsu T, Sawada M.

Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):781-802. Epub 2006 Jul 6. Review.

PMID:
16823625
[PubMed - indexed for MEDLINE]
14.
15.

Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.

Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh MS, Lee KT, Park S.

Neurotox Res. 2009 May;15(4):332-47. doi: 10.1007/s12640-009-9037-x. Epub 2009 Mar 17.

PMID:
19384567
[PubMed - indexed for MEDLINE]
16.

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.

van Muiswinkel FL, de Vos RA, Bol JG, Andringa G, Jansen Steur EN, Ross D, Siegel D, Drukarch B.

Neurobiol Aging. 2004 Oct;25(9):1253-62.

PMID:
15312971
[PubMed - indexed for MEDLINE]
17.

Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.

Sharma SK, Ebadi M.

Antioxid Redox Signal. 2003 Jun;5(3):251-64.

PMID:
12880480
[PubMed - indexed for MEDLINE]
18.

Protective effect of sulforaphane against dopaminergic cell death.

Han JM, Lee YJ, Lee SY, Kim EM, Moon Y, Kim HW, Hwang O.

J Pharmacol Exp Ther. 2007 Apr;321(1):249-56. Epub 2007 Jan 26.

PMID:
17259450
[PubMed - indexed for MEDLINE]
Free Article
19.

Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.

Yokoyama H, Kuroiwa H, Yano R, Araki T.

Neurol Sci. 2008 Oct;29(5):293-301. doi: 10.1007/s10072-008-0986-2. Epub 2008 Oct 21. Review.

PMID:
18941931
[PubMed - indexed for MEDLINE]
20.

Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.

Novikova L, Garris BL, Garris DR, Lau YS.

Neuroscience. 2006 Jun 19;140(1):67-76. Epub 2006 Mar 14.

PMID:
16533572
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk